Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 129 (RNA5SP129) is a non-functional, processed or unprocessed genomic sequence in humans that is homologous to 5S ribosomal RNA. It does not produce a functional RNA product and is not directly involved in therapeutic, signaling, or enzymatic processes. Despite being listed in genomic databases (Ensembl: ENSG00000222208, HGNC:43029), it is not a protein, receptor, enzyme, or transcription factor, but rather a pseudogene—generally considered biologically inert, although some pseudogenes can contribute to the regulation of gene networks in rare cases[2][4][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 129 (RNA5SP129).